Approval for the spiroflex vg catheter the device, as modified, will be marketed under the trade name the angiojet rheolytic thrombectomy system: spiroflex vg rapid exchange rheolytic thrombectomy catheter and is indicated for removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions in vessels >= 3 mm in diameter prior to balloon angioplasty or stent placement.